ArticleCell death & disease2018

Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells.

Yingshi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.